Takao Miyabayashi

Niigata, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Risk of lung injury with immune checkpoint inhibitors after talc pleurodesis: A retrospective study.

Risk of lung injury with immune checkpoint inhibitors after talc pleurodesis: A retrospective study.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: April 02, 2025

Real-world outcomes of chemotherapy for lung cancer patients undergoing hemodialysis: A multicenter retrospective cohort study (NEJ-042).

Real-world outcomes of chemotherapy for lung cancer patients undergoing hemodialysis: A multicenter retrospective cohort study (NEJ-042).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: April 06, 2022

Efficacy and safety of amrubicin therapy after chemoimmunotherapy in small cell lung cancer patients.

Efficacy and safety of amrubicin therapy after chemoimmunotherapy in small cell lung cancer patients.

Journal: Translational lung cancer research

Published: March 23, 2022

Observational study of rebiopsy in EGFR-TKI-resistant patients with EGFR mutation-positive advanced NSCLC.

Observational study of rebiopsy in EGFR-TKI-resistant patients with EGFR mutation-positive advanced NSCLC.

Journal: Scientific reports

Published: November 17, 2021

The Prognostic Significance of the Continuous Administration of Anti-PD-1 Antibody via Continuation or Rechallenge After the Occurrence of Immune-Related Adverse Events.

The Prognostic Significance of the Continuous Administration of Anti-PD-1 Antibody via Continuation or Rechallenge After the Occurrence of Immune-Related Adverse Events.

Journal: Frontiers in oncology

Published: May 03, 2021

Subsequent systemic therapy for non-small cell lung cancer patients with immune checkpoint inhibitor-related interstitial lung disease.

Subsequent systemic therapy for non-small cell lung cancer patients with immune checkpoint inhibitor-related interstitial lung disease.

Journal: Translational lung cancer research

Published: March 11, 2021

Prognostic significance of the radiologic features of pneumonitis induced by anti-PD-1 therapy.

Prognostic significance of the radiologic features of pneumonitis induced by anti-PD-1 therapy.

Journal: Cancer medicine

Published: December 28, 2019

Clinical Outcomes of Second-Line Chemotherapy in Patients with Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023 Study.

Clinical Outcomes of Second-Line Chemotherapy in Patients with Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023 Study.

Journal: The oncologist

Published: August 02, 2019

Spontaneous resolution of thoracic radiation therapy-induced organizing pneumonia: A case series.

Spontaneous resolution of thoracic radiation therapy-induced organizing pneumonia: A case series.

Journal: Respiratory medicine case reports

Published: November 08, 2018

IL-17 eliminates therapeutic effects of oral tolerance in murine airway allergic inflammation.

IL-17 eliminates therapeutic effects of oral tolerance in murine airway allergic inflammation.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Published: August 23, 2012

Depletion of radio-resistant regulatory T cells enhances antitumor immunity during recovery from lymphopenia.

Depletion of radio-resistant regulatory T cells enhances antitumor immunity during recovery from lymphopenia.

Journal: Blood

Published: July 19, 2012

Epitope diversification driven by non-tumor epitope-specific Th1 and Th17 mediates potent antitumor reactivity.

Epitope diversification driven by non-tumor epitope-specific Th1 and Th17 mediates potent antitumor reactivity.

Journal: Vaccine

Published: May 04, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026